In vitro activities of five antifungal agents against pathogenic Exophiala species

Chinese Medical Journal

Volumn 112, Issue 6, 1999, Pages 484-488

  Li, Dongming ^a   Li, Ruoyu ^a   Wang, Duanli ^a   Ma, Shengqing ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Antifungal agent; Exophiala; Microdilution

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; EXOPHIALA; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EXOPHIALA; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOSES;

EID: 0032979984     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sudduth EJ, Crumbley AJ 3rd, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of diseases in humans. Clin Infect Dis 1992;15:639-644.
2. Matsumoto T, Ajello L, Matsuda T, et al. Developments in hyalophmycosis and phaeohyphomycosis. J Med Vet Mycol 1994; 32 (Suppl 1):329-349.
3. Matsumoto T, McGinnis MR, Ajello LA. Clinical and mycological spectra of Wangiella dermatitidis. Mycoses 1993;36:145-155.
4. Kenney RT, Kwon-Chung KJ, Waytes AT, et al. Successfully treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infec Dis 1992;14:235-242.
5. Rex JH, Pfaller MA, Rinaldi MG, et al. Antifungal susceptibility testing. Clin Microbiol Rev 1993;6:367-381.
6. Reference method for broth microdilution antifungal susceptibility testing of yeasts: approved standard M27-A. The National Committee for Clinical Laboratory Standards (NCCLS). USA, Pennsylvania, 1997, 6.
7. Reference method for broth microdilution antifungal susceptibility testing of yeasts: tentative standard M27-T. The National Committee for Clinical Laboratory Standards (NCCLS). USA, Pennsylvania, 1997, 10.
8. Reference method for broth microdilution antifungal susceptibility testing of yeasts: proposed standard M27-P. The National Committee for Clinical Laboratory Standards (NCCLS). USA, Pennsylvania, 1997, 12.
9. Espinel-Ingroff A, Bartlett M, Bowden R, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997;35: 139-143.
10. Espinel-Ingroff A, Dawson K, Pfaller M, et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995;39: 314-319.
11. McGinnis MR, Pasarell L. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. Med Mycol 1998;36:243-246.
12. Li RY, Wang DL. Studies on phaeohyphomycosis and its causative agents in China. Jpn J Med Mycol 1996;37:135-141.
13. Pujol I, Guarro J, Sala J, et al. Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility treat results for amphotericin B against Fusarium. Antimicrob Agents Chemother 1997;41:808-811.
14. Gehrt A, Peter J, Pizzo PA, et al. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 1995;33:1302-1307.
15. Guarro J, Llop C, Aguilar C, et al. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997;41:2760-2762.